These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8279352)

  • 21. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J; Maier B; Behrens S; Thimme W
    Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited.
    Renkin J
    J Hypertens Suppl; 1996 Dec; 14(6):S15-9. PubMed ID: 9023710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
    Ball SG; Hall AS
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive therapy for acute myocardial infarction.
    Alexander J
    Curr Opin Cardiol; 1997 Sep; 12(5):453-8. PubMed ID: 9352172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.
    Teo KK; Yusuf S
    Drugs; 1993 Sep; 46(3):347-359. PubMed ID: 7693427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
    Flather MD; Yusuf S; Køber L; Pfeffer M; Hall A; Murray G; Torp-Pedersen C; Ball S; Pogue J; Moyé L; Braunwald E
    Lancet; 2000 May; 355(9215):1575-81. PubMed ID: 10821360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying the results of large clinical trials in the management of acute myocardial infarction.
    Sweeney JP; Schwartz GG
    West J Med; 1996 Mar; 164(3):238-48. PubMed ID: 8775936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of acute myocardial infarction.
    Saltissi S; Mushahwar SS
    Postgrad Med J; 1995 Sep; 71(839):534-41. PubMed ID: 7479465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of acute myocardial infarction in Auckland.
    French J; Williams B; Hart H; Woo K; Wang L; Grant J; Ingram C; O'Brien P; Poole J; Sharpe N; Williams M; White H
    N Z Med J; 1996 Jul; 109(1025):248-51. PubMed ID: 8692449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
    Campbell KR; Ohman EM; Cantor W; Lincoff AM
    Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction.
    Held PH; Yusuf S
    Eur Heart J; 1993 Oct; 14 Suppl F():18-25. PubMed ID: 7903243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.